WallStreetZenWallStreetZen

NASDAQ: ATTO
Attovia Therapeutics Inc Stock Ownership - Who owns Attovia Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Attovia Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Redmile Group LLC10% Owner2026-08-06400,000$17.00
$6.80MBuy
Frazier Life Sciences XI LP10% Owner2026-08-06588,235$17.00
$10.00MBuy
Sanofi10% Owner2026-08-06300,000$17.00
$5.10MBuy
Venbio Global Strategic Fund IV LP10% Owner2026-08-06382,352$17.00
$6.50MBuy
Goldman Sachs Group IncInsider2026-08-06500,000$17.00
$8.50MBuy
Goldman Sachs Group IncInsider2026-08-06500,000$17.00
$8.50MBuy
Goldman Sachs Group Inc 1Insider2026-08-06500,000$17.00
$8.50MBuy
Redmile Group LLC10% Owner2026-08-06200,000$17.00
$3.40MBuy
Colin WalshDirector2026-08-06500,000$17.00
$8.50MBuy
Colin WalshDirector2026-08-06500,000$17.00
$8.50MBuy

1 of 13

ATTO insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when ATTO insiders and whales buy or sell their stock.

ATTO Shareholders

What type of owners hold Attovia Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Frazier Life Sciences XI LP13.48%6,154,213$98.22MInsider
Venbio Global Strategic Fund IV LP9.16%4,181,367$66.73MInsider
Alamar Holdco LLC7.07%3,229,278$51.54MInsider
Goldman Sachs Group Inc 16.62%3,020,632$48.21MInsider
Goldman Sachs Group Inc6.62%3,020,632$48.21MInsider
Colin Walsh6.62%3,020,632$48.21MInsider
Redmile Group LLC4.74%2,165,708$34.56MInsider
Deep Track Biotechnology Master Fund Ltd4.29%1,957,138$31.24MInsider
Sanofi2.37%1,082,855$17.28MInsider
Tao Fu0.73%333,268$5.32MInsider

1 of 2

ATTO vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
ATTO0.00%62.92%Net Buying
ARDX0.07%90.93%Net SellingNet Selling
ABUS0.05%99.95%Net SellingNet Selling
OABI0.04%22.88%Net Selling
DNA0.01%99.99%Net SellingNet Selling
View Top Biotech Stocks

Attovia Therapeutics Stock Ownership FAQ

Who owns Attovia Therapeutics?

Attovia Therapeutics (NASDAQ: ATTO) is owned by 0.00% institutional shareholders, 62.92% Attovia Therapeutics insiders, and 37.08% retail investors. Frazier Life Sciences XI LP is the largest individual Attovia Therapeutics shareholder, owning 6.15M shares representing 13.46% of the company. Frazier Life Sciences XI LP's Attovia Therapeutics shares are currently valued at $102.41M.

If you're new to stock investing, here's how to buy Attovia Therapeutics stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.